Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.080
+0.170 (8.90%)
At close: Apr 1, 2025, 4:00 PM
2.000
-0.080 (-3.85%)
After-hours: Apr 1, 2025, 4:15 PM EDT
Sunshine Biopharma Employees
Sunshine Biopharma had 44 employees as of December 31, 2023. The number of employees decreased by 2 or -4.35% compared to the previous year.
Employees
44
Change (1Y)
-2
Growth (1Y)
-4.35%
Revenue / Employee
$749,079
Profits / Employee
-$96,044
Market Cap
4.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SBFM News
- 8 days ago - Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada - Accesswire
- 22 days ago - Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market - Accesswire
- 2 months ago - Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT - Accesswire
- 2 months ago - Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer - Accesswire
- 4 months ago - Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus - Accesswire
- 4 months ago - Sunshine Biopharma Launches a New Generic Prescription Drug - Accesswire
- 4 months ago - Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma - Accesswire
- 5 months ago - Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - Accesswire